(NP (NP (JJ Differential) (NN contribution)) (PP (IN of) (NP (NN herpes) (NN simplex) (NN virus) (NN type) (CD 1) (NP-COOD (NP (NN gene) (NNS products)) (CC and) (NP (JJ cellular) (NNS factors))))) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN provirus))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB previously)) (VP (VBN reported) (SBAR (IN that) (S (NP-SBJ (NP (NN infection)) (PP (IN with) (NP (NP (NN herpes) (NN simplex) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HSV-1)) (-RRB- -RRB-))))) (VP (VBZ activates) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN provirus))) (PP (IN in) (NP (NN T) (NNS cells))))))))) (. .))
(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (DT the) (NN HIV-1) (NN provirus)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP-COOD (NP (NP (NN binding)) (PP (IN of) (NP (ADJP-COOD (ADJP (NP (CD 55-)) (NP (-NONE- *?*))) (CC and) (ADJP (JJ 85-kDa))) (NNS proteins))) (PP (TO to) (NP (DT the) (NN kappa) (NN B) (NN enhancer)))) (CC and) (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (JJ 50-kDa) (NN HLP-1) (NN protein))) (PP (TO to) (NP (NP (DT the) (NN LBP-1) (NNS sequences)) (PP (IN of) (NP (DT the) (NN HIV-1) (JJ long) (JJ terminal) (NN repeat))))))))))) (. .))
(S (NP-SBJ (NP (RB Further) (NN examination)) (PP (IN of) (NP (DT this) (NN system)))) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN HSV-1) (NN replication))) (PP (IN by) (NP (DT the) (JJ antiviral) (NN drug) (NN acyclovir)))) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (NP (JJ HSV-1-mediated) (NN induction)) (PP (IN of) (NP (NN HIV-1) (NN provirus)))))))))) (. .))
(S (ADVP (RB Surprisingly)) (, ,) (NP-SBJ-1 (DT the) (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN HLP-1))) (NN binding) (NNS activities)) (VP (VBD were) (VP (ADVP (RB substantially)) (VBN inhibited) (NP (-NONE- *-1)) (PP (IN in) (NP (JJ acyclovir-treated) (NNS cells))))) (. .))
(S-COOD (S (PP (IN In) (NP (DT the) (JJ transient-transfection) (NN assay))) (, ,) (NP-SBJ-COOD (NP (NN ICP0)) (, ,) (CONJP (CC but) (RB not)) (NP (NN ICP4)) (, ,)) (VP (VBD activated) (NP (DT the) (NN HIV-1) (JJ long) (JJ terminal) (NN repeat) (NN promoter) (NN region)))) (CC and) (S (NP-SBJ-2 (NP (DT the) (NN effect)) (PP (IN of) (NP (NN ICP0)))) (VP (VBD was) (VP (ADVP (RB greatly)) (VBN enhanced) (NP (-NONE- *-2)) (PP (IN in) (DT the) (NN presence) (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN binding) (NNS proteins))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (NN induction)) (PP (IN of) (NP (DT the) (NN HIV-1) (NN provirus)))) (VP (VBZ involves) (NP (NP (NN cooperation)) (PP (IN between) (NP-COOD (NP (NP (DT the) (JJ HSV-1-activated) (JJ cellular) (NN factor)) (, ,) (NP (NN NF-kappa) (NN B))) (, ,) (CC and) (NP (NP (DT the) (JJ virus-encoded) (NN transactivator)) (, ,) (NP (NN ICP0)))))))))))))) (. .))
